Zevra Therapeutics (ZVRA) Stock Chart & Stock Price History $8.05 +0.41 (+5.42%) As of 02:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Zevra Therapeutics Stock Price Performance 5 Day Performance+9.65%1 Month Performance+3.07%3 Month Performance+0.70%6 Month Performance-6.01%Year-To-Date Performance-5.34%1 Year Performance+66.21% Receive ZVRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ZVRA Stock Chart for Friday, May, 2, 2025 ZVRA Chart by TradingView Zevra Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$7.33$7.64+4.23%$7.90$7.19743,479 shs$417.75 million04/30/2025$7.23$7.33+1.38%$7.42$7.15275,448 shs$400.80 million04/29/2025$7.20$7.23+0.42%$7.35$7.11334,199 shs$395.33 million04/28/2025$7.20$7.20$7.26$7.15249,095 shs$393.69 million04/25/2025$7.24$7.20-0.55%$7.21$7.04381,265 shs$393.69 million04/24/2025$7.25$7.24-0.14%$7.29$7.01424,601 shs$391.80 million04/23/2025$7.31$7.25-0.82%$7.55$7.23462,788 shs$392.34 million04/22/2025$6.87$7.31+6.40%$7.37$6.93564,146 shs$395.59 million04/21/2025$7.15$6.87-3.92%$7.11$6.85363,613 shs$371.78 million04/18/2025$7.15$7.15$7.27$6.89406,058 shs$386.93 million Get the Latest News and Ratings for ZVRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$7.05$7.15+1.42%$7.27$6.89406,058 shs$386.93 million04/16/2025$6.96$7.05+1.29%$7.06$6.77338,170 shs$381.52 million04/15/2025$6.98$6.96-0.29%$7.15$6.90783,842 shs$376.65 million04/14/2025$6.90$6.98+1.16%$7.22$6.88388,088 shs$377.73 million04/11/2025$6.56$6.90+5.18%$6.95$6.52663,337 shs$373.40 million04/10/2025$6.85$6.56-4.23%$6.68$6.32380,642 shs$355.00 million04/09/2025$6.59$6.85+3.95%$7.02$6.19678,745 shs$370.70 million04/09/2025$6.59$6.85+3.95%$7.02$6.19678,745 shs$370.70 million04/08/2025$7.05$6.59-6.52%$7.40$6.55569,512 shs$356.62 million04/08/2025$7.05$6.59-6.52%$7.40$6.55569,512 shs$356.62 million04/07/2025$7.04$7.05+0.14%$7.41$6.63921,212 shs$381.52 million04/04/2025$7.43$7.04-5.25%$7.35$6.90580,412 shs$380.98 million04/03/2025$7.66$7.43-3.00%$7.53$7.30450,725 shs$402.08 million04/02/2025$7.32$7.66+4.64%$7.68$7.19577,002 shs$414.53 million04/01/2025$7.49$7.32-2.27%$7.63$7.26398,559 shs$396.13 million Related Companies Disc Medicine Stock Price Chart Edgewise Therapeutics Stock Price Chart Kiniksa Pharmaceuticals Stock Price Chart ANI Pharmaceuticals Stock Price Chart Immunocore Stock Price Chart Mesoblast Stock Price Chart Evotec Stock Price Chart Vera Therapeutics Stock Price Chart Structure Therapeutics Stock Price Chart ARS Pharmaceuticals Stock Price Chart Receive ZVRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVRA) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zevra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
